BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20394176)

  • 1. Low-dose transdermal testosterone augmentation therapy improves depression severity in women.
    Miller KK; Perlis RH; Papakostas GI; Mischoulon D; Losifescu DV; Brick DJ; Fava M
    CNS Spectr; 2009 Dec; 14(12):688-94. PubMed ID: 20394176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study.
    Dichtel LE; Carpenter LL; Nyer M; Mischoulon D; Kimball A; Deckersbach T; Dougherty DD; Schoenfeld DA; Fisher L; Cusin C; Dording C; Trinh NH; Pedrelli P; Yeung A; Farabaugh A; Papakostas GI; Chang T; Shapero BG; Chen J; Cassano P; Hahn EM; Rao EM; Brady RO; Singh RJ; Tyrka AR; Price LH; Fava M; Miller KK
    Am J Psychiatry; 2020 Oct; 177(10):965-973. PubMed ID: 32660299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial.
    Amiaz R; Pope HG; Mahne T; Kelly JF; Brennan BP; Kanayama G; Weiser M; Hudson JI; Seidman SN
    J Sex Marital Ther; 2011; 37(4):243-54. PubMed ID: 21707327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular testosterone supplementation to selective serotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo-controlled clinical trial.
    Seidman SN; Miyazaki M; Roose SP
    J Clin Psychopharmacol; 2005 Dec; 25(6):584-8. PubMed ID: 16282843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone administration in women with anorexia nervosa.
    Miller KK; Grieco KA; Klibanski A
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1428-33. PubMed ID: 15613421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
    J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder.
    Sato Y; Yasui-Furukori N; Nakagami T; Saito M; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):416-8. PubMed ID: 19166896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment.
    Pope HG; Amiaz R; Brennan BP; Orr G; Weiser M; Kelly JF; Kanayama G; Siegel A; Hudson JI; Seidman SN
    J Clin Psychopharmacol; 2010 Apr; 30(2):126-34. PubMed ID: 20520285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.
    Davis S; Papalia MA; Norman RJ; O'Neill S; Redelman M; Williamson M; Stuckey BG; Wlodarczyk J; Gard'ner K; Humberstone A
    Ann Intern Med; 2008 Apr; 148(8):569-77. PubMed ID: 18413618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study.
    Dichtel LE; Nyer M; Dording C; Fisher LB; Cusin C; Shapero BG; Pedrelli P; Kimball AS; Rao EM; Mischoulon D; Fava M; Miller KK
    J Clin Psychiatry; 2020 Jun; 81(4):. PubMed ID: 32558402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
    Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
    Expert Opin Pharmacother; 2008 Dec; 9(18):3145-9. PubMed ID: 19040335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
    Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
    J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.
    Zimmerman M; Posternak MA; Chelminski I
    J Psychiatr Res; 2004; 38(6):577-82. PubMed ID: 15458853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
    Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA
    J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine augmentation of treatment-resistant depression: a comparison with lithium.
    Dorée JP; Des Rosiers J; Lew V; Gendron A; Elie R; Stip E; Tourjman SV
    Curr Med Res Opin; 2007 Feb; 23(2):333-41. PubMed ID: 17288688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy.
    Orengo CA; Fullerton L; Kunik ME
    J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):20-4. PubMed ID: 15681624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.
    Simon JS; Nemeroff CB
    J Clin Psychiatry; 2005 Oct; 66(10):1216-20. PubMed ID: 16259533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS).
    Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
    Aging Male; 2012 Mar; 15(1):14-21. PubMed ID: 22092151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.